학술논문
Combination chemotherapy consisting of irinotecan, etoposide, and carboplatin for refractory or relapsed neuroblastoma
Document Type
Article
Author
Source
In: Cancer Medicine . (Cancer Medicine, May 2022, 11(9):1956-1964)
Subject
Language
English
ISSN
20457634